Zemel BS, Kawchak DA, Fung EB, et. al. Effect of zinc supplementation on growth and body composition in children with sickle cell disease.
Am J Clin Nutr.
2002;75:300–307.
Gupta VL, Chaubey BS. Efficacy of zinc therapy in prevention of crisis in sickle-cell anemia: a double-blind, randomized controlled clinical trial.
J Assoc Physicians India.
1995;43:467–469.
Serjeant GR, Galloway RE, Gueri MC. Oral zinc sulphate in sickle-cell ulcers.
Lancet.
1970;2:891–893.
Tomer A, Kasey S, Connor WE, et al. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids.
Thromb Haemost.
2001;85:966–974.
Ajayi OA, George BO, Ipadeola T. Clinical trial of riboflavin in sickle cell disease.
East Afr Med J.
1993;70:418–421.
al-Momen AK. Diminished vitamin B12 levels in patients with severe sickle cell disease.
J Intern Med.
1995;237:551–555.
Ballas SK. Short Report: Hydration of sickle erythrocytes using a herbal extract (
Pfaffia paniculata) in vitro.
Br J Haematol.
2000;111:359–362.
Chiu D, Vichinsky E, Ho SL, et al. Vitamin C deficiency in patients with sickle cell anemia.
Am J Pediatr Hematol Oncol.
1990;12:262–267.
De Franceschi L, Bachir D, Balacteros F, et al. Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease.
J Clin Invest.
1997;100:1847–1852.
De Franceschi L, Bachir D, Balacteros F, et al. Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease.
Br J Haematol.
2000;108:284–289.
Essein, EU. Plasma levels of retinol, ascorbic acid and alpha-tocopherol in sickle cell anemia.
Centr Afr J Med.
1995;41:48–50.
Flores L,
Pais R, Buchanan I, et al. Pyridoxal 5’-phosphate levels in children with sickle cell disease.
Am J Pediatr Hematol Oncol.
1988;10:236–240.
Jain SK, Ross JD, Duett J, et al. Low plasma prealbumin and
carotenoid levels in sickle cell disease patients.
Am J Med Sci.
1990;229:13–15.
Jain SK, Williams DM. Reduced levels of plasma ascorbic acid (vitamin C) in sickle cell disease patients: its possible role in the oxidant damage to sickle cells in vitro.
Clin Chim Acta.
1985;149:257–261.
Kark JA, Kale MP, Tarassoff PG, et al. Inhibition of erythrocyte sickling in vitro by pyridoxal.
J Clin Invest.
1978;62:888–891.
Kark JA, Tarassoff PG, Bongiovanni R. Pyridoxal phosphate as an antisickling agent in vitro.
J Clin Invest.
1983;71:1224–1229.
Muskiet FA, Muskiet FD, Meiborg G, et al. Supplementation of patients with homozygous sickle cell disease with zinc, alpha-tocopherol, vitamin C, soybean oil, and fish oil.
Am J Clin Nutr.
1991;54:736–744.
Natta C, Stacewicz-Sapuntzakis M, Bhagavan H, et al. Low serum levels of carotenoids in sickle cell anemia.
Eur J Haematol.
1988;41:131–135.
Natta CL, Machlin LJ, Brin M. A decrease in irreversibly sickled erythrocytes in sickle cell anemia patients given vitamin E.
Am J Clin Nutr.
1980;33:968–971.
Natta CL, Reynolds RD. Apparent vitamin B6 deficiency in sickle cell anemia.
Am J Clin Nutr.
1984;40:235–239.
Ndombi IO, Kinoti SN. Serum vitamin E and the sickling status in children with sickle cell anemia.
East Afr Med J.
1990;67:720–725.
Ohnishi ST, Ohnishi T, Ogunmola GB. Sickle cell anemia: A potential nutritional approach for a molecular disease.
Nutrition.
2000;16:330–338.
Osifo BO, Adeyokunnu A, Parmentier Y, et al. Abnormalities of serum transcobalamins in sickle cell disease (HbSS) in Black Africa.
Scand J Haematol.
1983;30:135–140.
Phillips G, Tangney CC. Relationship of plasma alpha tocopherol to index of clinical severity in individuals with sickle cell anemia.
Am J Hematol.
1992;41:227–231.
Reed JD, Redding-Lallinger R, Orringer EP. Nutrition and sickle cell disease.
Am J Hematol.
1987;24:441–455 .
Tangney CC, Phillips G, Bell RA, et al. Selected indices of micronutrient status in adult patients with sickle cell anemia (SCA).
Am J Hematol.
1989;32:161–166.
van der Dijs FP, Schnog JJ, Brouwer DA, et al. Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients.
Am J Hematol.
1998;59:192–198.
Wambebe C, Khamofu H, Momoh JA, et al. Double-blind, placebo-controlled, randomised cross-over clinical trial of NIPRISAN in patients with Sickle Cell Disorder.
Phytomedicine. 2001;8:252–261.
Bao B, Prasad AS, Beck FW, et al. Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients.
Transl Res.
2008;152:67-80.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.